North Star Asset Management Inc. acquired a new stake in Roche Holding AG (OTCMKTS:RHHBY – Free Report) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 26,305 shares of the company’s stock, valued at approximately $1,351,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. McIlrath & Eck LLC purchased a new position in shares of Roche during the 1st quarter worth approximately $39,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Roche in the fourth quarter valued at approximately $192,000. Pinnacle Wealth Management Advisory Group LLC acquired a new position in Roche during the first quarter worth $208,000. Enterprise Financial Services Corp grew its holdings in Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after acquiring an additional 345 shares during the period. Finally, Archer Investment Corp raised its position in Roche by 7.7% in the first quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock worth $278,000 after acquiring an additional 398 shares in the last quarter.
Wall Street Analyst Weigh In
Several brokerages have commented on RHHBY. Zacks Research upgraded shares of Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, August 24th. HSBC downgraded shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Finally, Morgan Stanley raised shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective on the stock in a report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Roche presently has an average rating of “Hold” and an average price target of $60.00.
Roche Stock Performance
Shares of RHHBY stock opened at $55.19 on Friday. Roche Holding AG has a fifty-two week low of $39.50 and a fifty-two week high of $60.85. The business has a fifty day simple moving average of $53.94 and a 200-day simple moving average of $52.95. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38.
About Roche
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.
Featured Articles
- Five stocks we like better than Roche
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
